Joint Formulary & PAD

Seladelpar - Primary biliary cholangitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Capsules
Associated Icons :
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Seladelpar
Indication :
Primary biliary cholangitis
Group Name :
Keywords :
Brand Names Include :
Livdelzi
Important Information :

Previously treated primary biliary cholangitis in line with NICE TA 1171

https://www.nice.org.uk/guidance/ta1171

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Seladelpar is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Primary biliary cholangitis.